Erudio Healtherudio.com
Drug
Panitumumab trials: what clinicians said in public
No HCP commentary report on a trial studying panitumumab yet. Erudio has found public clinician commentary on 7 clinical trials studying panitumumab, including CodeBreaK 101, CodeBreaK 300, PARERE and PUMP. Each trial's page lists the podcasts, videos and posts found so far and the price of a report.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| CodeBreaK 300 NCT05198934 · Amgen DeepView → | KRAS G12C-mutated chemorefractory metastatic colorectal cancer | Phase 3 | Deep | View | |||
| PUMP NCT05863195 · ECOG-ACRIN Cancer Research Group DeepView → | unresectable colorectal liver metastases | Phase 3 | Deep | View | |||
| CodeBreaK 101 NCT04185883 · Amgen DeepView → | KRAS G12C-mutated advanced solid tumors | Phase 1 | Deep | View | |||
| PARERE NCT04787341 · Gruppo Oncologico del Nord-Ovest DeepView → | RAS and BRAF wild-type chemorefractory metastatic colorectal cancer | Phase 2 | Deep | View | |||
| BBOpCo NCT06268015 · Nicholas DeVito, MD FocusedView → | first-line microsatellite stable metastatic colorectal cancer | Phase 2 | Focused | View | |||
| TARGET-D 203 NCT07659795 · Verastem, Inc. FocusedView → | metastatic KRAS G12D-mutated colorectal adenocarcinoma | Phase 2 | Focused | View | |||
| REVERCE II NCT04117945 · Academic and Community Cancer Research United FocusedView → | Not given | Phase 2 | Focused | View | |||